Vectura, GB00B01D1K48

ISIN: GB00B01D1K48 WKN: A0D8J4 Vectura Group Plc is a pulmonary drug development company focused principally on the development of a range of inhaled pharmaceuticalsfor the treatment of respiratory and neurological diseases.

23.12.2011 - 15:21:01

Vectura

Vectura has eight marketed products and a portfolio of drugs in clinical and pre-clinical development, some of which have been licensed to major pharmaceutical companies. The Companyalsoprogresses certain programmes to a more advanced stage tooptimise their commercial value. In addition, Vecturaoffers its formulation and inhalation capabilities to other pharmaceutical companies on a licensing basis where thiscomplements Vectura’s business strategy.

Vectura was formed in 1997 with venture finance backing. Its aim wasto develop and commercialise opportunities based on the technologies that were emerging in the fast- growing drug delivery field.

Vectura is based in the UK, with headquarters and development operations in Chippenham, Wiltshire,further laboratories in Nottingham, and device development in Cambridge.

In 2007, Vectura acquired Innovata plc, a UK listed company that was developing pulmonary products using specialised device and formulation technologies and with a portfolio of marketed, revenue-generating products.

In July 2007 Vectura moved from AIM to the Official List on the London Stock Exchange. Its shares trade on the London Stock Exchange under the symbol VEC.
@ ad-hoc-news.de